MaaT Pharma

European Union flag
Pharma

Europe's CHMP reverses endorsement of Amgen's Tavneos

The CHMP has now determined that the Advocate study was “conducted in breach of good clinical practice (GCP) principles,” the EU agency said.
Fraiser Kansteiner Jun 26, 2026 11:07am